PaxMedica Inc. (NASDAQ: PXMD) PRV Sale Prospects Strengthened by Recent Industry Developments
PaxMedica, with the help of financial services firm Bourne Partners, is actively exploring presale of its Priority Review Voucher (“PRV”),…
PaxMedica, with the help of financial services firm Bourne Partners, is actively exploring presale of its Priority Review Voucher (“PRV”),…
Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a cybersecurity and internet privacy provider of Swiss hosted solutions for…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared an open letter to shareholders from CEO David…
Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital…
PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, is working with leading financial services firm…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs,…
Application showed an improvement of 50% in customer rewards program effectiveness for the same amount of budget Italian fintech company…
Rat populations have created concerns for centuries because of their potential to be a vector for diseases, their destruction of…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announced that it is now taking orders…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today…